Neither the author, Tim Fries, nor this website, The Tokenist, provide financial advice. Please consult our website policy prior to making financial decisions.
Patterson Companies, Inc. (NASDAQ: PDCO) reported its fiscal 2024 fourth-quarter results, showcasing a slight increase in net sales by 0.1% year-over-year, amounting to $1.72 billion. Despite the modest growth in overall sales, internal sales experienced a minor decline of 0.5%. The company faced a challenging market environment but managed to maintain stable performance, driven primarily by strong growth in production animal and dental consumables segments, which saw a 3.7% year-over-year increase.
The fourth quarter’s GAAP earnings per diluted share were reported at $0.74, while adjusted earnings per diluted share were $0.82. Both figures were negatively impacted by $0.04 per diluted share due to a cybersecurity attack on Change Healthcare, a vendor partner. Net income attributable to Patterson Companies, Inc. for the quarter stood at $67.0 million, compared to $75.0 million in the same period last year. This decline is primarily attributed to lower equipment sales and the aforementioned cybersecurity incident.
In the dental segment, reported net sales were $657.8 million, with internal sales decreasing by 3.8% year-over-year. However, internal sales of dental consumables increased by 3.7%, excluding the deflationary impact of certain infection control products. The animal health segment reported net sales of $1.06 billion, with internal sales growth of 2.5% driven by the production animal business. This segment also saw a notable increase in value-added services by 15.0%.
Patterson Companies, Inc. (PDCO) Beats EPS Expectations by $0.01
Patterson Companies’ fourth-quarter performance slightly missed the expectations set by analysts. The expected earnings per share (EPS) for the quarter were $0.83, while the actual adjusted EPS came in at $0.82. Although the difference is minimal, it highlights the impact of unforeseen challenges, such as the cybersecurity attack, on the company’s financial performance. Additionally, the expected revenue for the quarter was $1.7 billion, and the company exceeded this expectation marginally with reported net sales of $1.72 billion.
The company’s ability to meet revenue expectations while slightly missing the EPS target indicates a resilient business model but also underscores the need for improved operational efficiency. The decline in net income compared to the previous year further emphasizes the impact of external factors and the importance of strategic adjustments to mitigate such risks. The dental segment’s internal sales decline of 3.8% contrasts with the overall positive performance in consumables, suggesting a need for targeted strategies to boost equipment and value-added services sales.
Despite these challenges, Patterson Companies demonstrated a robust performance in the animal health segment, with internal sales growth driven by consumables and value-added services. This segment’s success highlights the company’s strong positioning in the production animal market and its potential for future growth.
Join our Telegram group and never miss a breaking story.
Patterson Companies Expect $2.23 to $2.43 Adjusted EPS for FY 2025
Looking ahead to fiscal 2025, Patterson Companies has issued guidance for both GAAP and non-GAAP adjusted earnings. The company expects GAAP earnings to be between $2.00 and $2.10 per diluted share and non-GAAP adjusted earnings to be between $2.33 and $2.43 per diluted share.
The guidance also takes into account the expected impact of deal amortization expenses, estimated at approximately $29.1 million or $0.33 per diluted share.
Disclaimer: The author does not hold or have a position in any securities discussed in the article.
The post Patterson Companies Beats EPS Forecast by $0.01 in Fiscal Q4 appeared first on Tokenist.